BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8605776)

  • 1. Albunex and beyond.
    Ostensen J
    Clin Radiol; 1996 Feb; 51 Suppl 1():8-10. PubMed ID: 8605776
    [No Abstract]   [Full Text] [Related]  

  • 2. Albunex--a new ultrasound contrast agent. Effects on hemodynamics, contrast, and biodistribution in different species.
    Walday P; Ostensen J; Tolleshaug H; Holtz E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S142-4. PubMed ID: 7928211
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultrasound scattering properties of Albunex microspheres].
    Takamoto T; Shiina T
    Nihon Rinsho; 1998 Apr; 56(4):871-5. PubMed ID: 9577600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic evaluation of intervillous flow in early pregnancy: use of echo-enhancement agents.
    Simpson NA; Nimrod C; De Vermette R; Leblanc C; Fournier J
    Ultrasound Obstet Gynecol; 1998 Mar; 11(3):204-8. PubMed ID: 9589145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in echo-enhancing agents.
    Schlief R
    Clin Radiol; 1996 Feb; 51 Suppl 1():5-7. PubMed ID: 8605773
    [No Abstract]   [Full Text] [Related]  

  • 6. EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids.
    Correas JM; Quay SD
    Clin Radiol; 1996 Feb; 51 Suppl 1():11-4. PubMed ID: 8605764
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of changes in skeletal muscle blood flow in the dog with contrast ultrasonography revisited: has the technique been useful, and where are we headed now?
    Lohman RF; Schechter LS; Zachary LS; Aronson S
    Plast Reconstr Surg; 2003 Apr; 111(4):1477-80. PubMed ID: 12618609
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology.
    Burns PN
    J Neuroimaging; 1997 Apr; 7 Suppl 1():S2-14. PubMed ID: 9128460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound contrast. Oral and i.v. agents amplify the image.
    Barr RG
    Diagn Imaging (San Franc); 1999 Mar; 21(3):56-61. PubMed ID: 10351114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ultrasonographic contrast media].
    Drudi F
    Radiol Med; 2004 Apr; 107(4 Suppl 1):36-7. PubMed ID: 15323321
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Albunex infusion on left ventricular inflow velocity in dogs.
    Tomita M; Wada H; Tanaka R; Miwa Y; Kagawa K; Noda T; Nishigaki K; Hirakawa S; Fujiwara H
    J Cardiol; 1997 May; 29(5):283-91. PubMed ID: 9174884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncardiac applications of Albunex.
    Wible JH; Adams MD; Sherwin PF; Wojdyla JK; Parsons AK; Atala A; Fowlkes JB; Needleman L
    Invest Radiol; 1994 Jun; 29 Suppl 2():S145-8. PubMed ID: 7928212
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs.
    Wible JH; Wojdyla JK; Bales GL; McMullen WN; Geiser EA; Buss DD
    J Am Soc Echocardiogr; 1996; 9(4):442-51. PubMed ID: 8827627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of renal blood flow with contrast ultrasonography.
    Aronson S; Wiencek JG; Feinstein SB; Heidenreich PA; Zaroff JG; Walker R; Roizen MF
    Anesth Analg; 1993 May; 76(5):964-70. PubMed ID: 8484552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound contrast agents in liver imaging.
    Leen E; McArdle CS
    Clin Radiol; 1996 Feb; 51 Suppl 1():35-9. PubMed ID: 8605770
    [No Abstract]   [Full Text] [Related]  

  • 17. Consideration about the contribution to acoustic backscatter from Albunex microspheres with different sizes.
    Hoff L; Christiansen C; Skotland T
    J Ultrasound Med; 1994 Mar; 13(3):181-2. PubMed ID: 7932974
    [No Abstract]   [Full Text] [Related]  

  • 18. Transmission measurements of Albunex attenuation and phase velocity at concentrations approaching in vivo doses.
    Adams M; Marsh JN; Hall CS; Mobley J; Hughes MS; Miller JG; Brandenburger GH
    Acad Radiol; 1996 Aug; 3 Suppl 2():S182-4. PubMed ID: 8796556
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of technetium-labelled human albumin microspheres for studies of the coronary circulation.
    Weller DA; Wellman HN; Adolph RJ
    J Lab Clin Med; 1971 Nov; 78(5):807-8. PubMed ID: 5128847
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of Albunex: air-filled albumin microspheres for echocardiography contrast enhancement.
    Barnhart J; Levene H; Villapando E; Maniquis J; Fernandez J; Rice S; Jablonski E; Gjøen T; Tolleshaug H
    Invest Radiol; 1990 Sep; 25 Suppl 1():S162-4. PubMed ID: 2126533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.